U.S. Bancorp Increases Holdings in Amgen Inc.

Summary

American National Bank & Trust increased its holdings in Amgen Inc. by 2.8% during Q2, now owning 36,316 shares valued at $10.14 million. The stock opened at $271.18, down 2.9%, with a market cap of $145.99 billion. Amgen reported $6.02 EPS for the last quarter, exceeding estimates, and announced a quarterly dividend of $2.38.Market Beat

Impact Analysis

So basically, American National Bank & Trust’s decision to increase its stake in Amgen by 2.8% is a vote of confidence in the company’s strong financial performance, despite the stock’s recent dip of 2.9% to $271.18. Amgen’s robust earnings of $6.02 per share, which exceeded estimates, and a solid dividend yield of 3.3% are likely key factors driving this move Market Beat. The interesting part isn’t just the increase itself, but the timing—right after a price drop, suggesting they see this as a buying opportunity. However, the technical analysis paints a bearish picture with a long-term downtrend and MACD death cross, indicating potential further downside . The market might be underestimating Amgen’s ability to maintain its earnings momentum, which could make this a contrarian play. Watching how other institutional investors react could provide further clues on sentiment shifts.